Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.45
-0.19 (-2.86%)
At close: May 29, 2026, 4:00 PM EDT
6.50
+0.05 (0.78%)
After-hours: May 29, 2026, 7:43 PM EDT
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Vanda Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $14.9. The average 1-year stock price forecast is 131.01% higher than the current stock price, while the lowest is $7.50 (+16.28%) and the highest is $21 (+225.58%).
Price Target: $14.9 (+131.01%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $24 → $21 | Buy | Reiterates | $24 → $21 | +225.58% | May 11, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $18 | Buy | Maintains | $18 | +179.07% | May 7, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +163.57% | Feb 25, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 | Buy | Maintains | $11 | +70.54% | Feb 23, 2026 |
| Jefferies | Jefferies | Hold Maintains $5 → $7.5 | Hold | Maintains | $5 → $7.5 | +16.28% | Dec 31, 2025 |
Financial Forecast
Revenue This Year
268.09M
from 216.11M
Increased by 24.06%
Revenue Next Year
363.36M
from 268.09M
Increased by 35.54%
EPS This Year
-2.36
from -3.74
EPS Next Year
-0.90
from -2.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 280.4M | 395.9M | |
| Avg | 268.1M | 363.4M | |
| Low | 254.5M | 331.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 29.7% | 47.7% | |
| Avg | 24.1% | 35.5% | |
| Low | 17.8% | 23.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.08 | -0.38 | |
| Avg | -2.36 | -0.90 | |
| Low | -2.63 | -1.29 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.